PT  - JOURNAL ARTICLE
AU  - Iona Coltart
AU  - Laura Blackmore
AU  - Jane Caisley
AU  - Adam Harris
TI  - Parenteral methotrexate for patients with Crohn's disease: how to develop a high-quality and safe self-administration service
AID  - 10.1136/flgastro-2011-100021
DP  - 2012 Jan 01
TA  - Frontline Gastroenterology
PG  - 36--38
VI  - 3
IP  - 1
4099  - http://fg.bmj.com/content/3/1/36.short
4100  - http://fg.bmj.com/content/3/1/36.full
SO  - Frontline Gastroenterol2012 Jan 01; 3
AB  - Parenteral methotrexate is recommended for patients with Crohn's disease who have failed treatment with thiopurines. There is no good evidence for the use of oral methotrexate, yet patients frequently receive this due to the difficulties associated with prescribing and administering an unlicensed, cytotoxic drug. We present our experience of developing a local service to provide our patients with the option to self-administer parenteral methotrexate in a safe and structured manner at home.